Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (horizons-ami) trial

American Journal of Cardiology

Volumn 111, Issue 2, 2013, Pages 196-201

  Fiocca, Luigi ^a   Guagliumi, Giulio ^a   Rossini, Roberta ^a   Parise, Helen ^b   Musumeci, Giuseppe ^a   Sirbu, Vasile ^a   Lortkipanidze, Nikoloz ^a   Yu, Jennifer ^c   Mihalcsik, Laurian ^a   Vassileva, Angelina ^a   Valsecchi, Orazio ^a   Gavazzi, Antonello ^a   Mehran, Roxana ^b,c   Stone, Gregg W ^b  

^a OSPEDALI RIUNITI   (Italy)

^b NewYork Presbyterian Hospital   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN; HEPARIN; HIRULOG;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARE METAL STENT; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEATH; DRUG ELUTING STENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INDEPENDENT VARIABLE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84872042985     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.09.019     Document Type: Article

References (23)

1. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P.G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, M. Weis ESC Committee for Practice Guidelines (CPG) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
2. P.G. Steg, J. López-Sendón, E. Lopez de Sa, S.G. Goodman, J.M. Gore, F.A. Anderson Jr., D. Himbert, J. Allegrone, F. Van de Werf GRACE Investigators External validity of clinical trials in acute myocardial infarction Arch Intern Med 167 2007 68 73
3. P.M. Rothwell External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 365 2005 82 93
4. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
5. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, M. Möckel, A. Ochala, A. Kellock, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
6. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, M. Fahy, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
7. N. Brown, M. Melville, D. Gray, T. Young, A.M. Skene, R.G. Wilcox, and J.R. Hampton Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four-year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis Heart 81 1999 598 602
8. M.C. Bahit, C.P. Cannon, E.M. Antman, S.A. Murphy, C.M. Gibson, and C.H. McCabe Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 trial and TIMI 9 registry Am Heart J 145 2003 109 117
9. P. Jha, D. Deboer, K. Sykora, and C.D. Naylor Characteristics and mortality outcomes of thrombolysis trial participants and non-participants: a population-based comparison J Am Coll Cardiol 27 1996 1335 1342
10. S. Behar, S. Gottlieb, H. Hod, B. Benari, R. Narinsky, H. Pauzner, E. Rechavia, H.E. Faibel, A. Katz, A. Roth, E. Goldhammer, N.A. Freedberg, N. Rougin, O. Kracoff, C. Shapira, J. Jafari, C. Lotan, F. Daka, T. Weiss, M. Kanetti, M. Klutstein, L. Rudnik, E. Barasch, N. Mahul, and D. Blondheim The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Israeli Thrombolytic Survey Group Am J Med 101 1996 184 191
11. C.L. Grines, D.A. Cox, G.W. Stone, E. Garcia, L.A. Mattos, A. Giambartolomei, B.R. Brodie, O. Madonna, M. Eijgelshoven, A.J. Lansky, W.W. O'Neill, and M.C. Morice Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 341 1999 1949 1956
12. G.W. Stone, C.L. Grines, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J.D. Carroll, B.D. Rutherford, A.J. Lansky Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
13. C. Spaulding, P. Henry, E. Teiger, K. Beatt, E. Bramucci, D. Carrié, M.S. Slama, B. Merkely, A. Erglis, M. Margheri, O. Varenne, A. Cebrian, H.P. Stoll, D.B. Snead, C. Bode TYPHOON Investigators Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104
14. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
15. K.A. Fox, O.H. Dabbous, R.J. Goldberg, K.S. Pieper, K.A. Eagle, F. Van de Werf, A. Avezum, S.G. Goodman, M.D. Flather, F.A. Anderson Jr., and C.B. Granger Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 2006 1091 1094
16. W.J. Rogers, P.D. Frederick, E. Stoehr, J.G. Canto, J.P. Ornato, C.M. Gibson, C.V. Pollack Jr., J.M. Gore, N. Chandra-Strobos, E.D. Peterson, and W.J. French Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1026 1034
17. H.L. Dauerman, D.S. Pinto, K.K. Ho, C.M. Gibson, R.E. Kuntz, D.J. Cohen, D.S. Baim, and J.P. Carrozza Jr. Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials Catheter Cardiovasc Interv 49 2000 237 243
18. A. Halkin, G.W. Stone, C.L. Grines, D.A. Cox, T.D. Stuckey, E. Garcia, G. Guagliumi, R. Mehran, B.D. Rutherford, J.J. Griffin, Y. Na, J.E. Tcheng, and M. Turco Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC Registry) Am J Cardiol 96 2005 1649 1655
19. O. Koeth, R. Zahn, A.K. Gitt, T. Bauer, C. Juenger, J. Senges, U. Zeymer Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry) Am J Cardiol 104 2009 1074 1077
20. R. Mehran, S. Pocock, E. Nikolsky, G.D. Dangas, T. Clayton, B.E. Claessen, A. Caixeta, F. Feit, S.V. Manoukian, H. White, M. Bertrand, E.M. Ohman, H. Parise, A.J. Lansky, A.M. Lincoff, and G.W. Stone Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trials JACC Cardiovasc Interv 4 2011 654 664
21. P. Généreux, R. Mehran, T. Palmerini, A. Caixeta, A.J. Kirtane, A.J. Lansky, B.R. Brodie, B. Witzenbichler, M. Mockel, G. Guagliumi, J.Z. Peruga, D. Dudek, M.P. Fahy, G. Dangas, and G.W. Stone Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial EuroIntervention 7 2011 905 916
22. S.P. de Boer, M.J. Lenzen, R.M. Oemrawsingh, C. Simsek, H.J. Duckers, W.J. van der Giessen, P.W. Serruys, and E. Boersma Evaluating the "all-comers" design: a comparison of participants in two "all-comers" PCI trials with non-participants Eur Heart J 32 2011 2161 2167
23. P.C. Austin, M.M. Mamdani, T.A. Stukel, G.M. Anderson, and J.V. Tu The use of the propensity score for estimating treatment effects: administrative versus clinical data Stat Med 24 2005 1563 1578